These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
244 related articles for article (PubMed ID: 26588471)
1. Early Gelatinase Activity Is Not a Determinant of Long-Term Recovery after Traumatic Brain Injury in the Immature Mouse. Semple BD; Noble-Haeusslein LJ; Gooyit M; Tercovich KG; Peng Z; Nguyen TT; Schroeder VA; Suckow MA; Chang M; Raber J; Trivedi A PLoS One; 2015; 10(11):e0143386. PubMed ID: 26588471 [TBL] [Abstract][Full Text] [Related]
2. Selective inhibition of matrix metalloproteinase-9 attenuates secondary damage resulting from severe traumatic brain injury. Hadass O; Tomlinson BN; Gooyit M; Chen S; Purdy JJ; Walker JM; Zhang C; Giritharan AB; Purnell W; Robinson CR; Shin D; Schroeder VA; Suckow MA; Simonyi A; Sun GY; Mobashery S; Cui J; Chang M; Gu Z PLoS One; 2013; 8(10):e76904. PubMed ID: 24194849 [TBL] [Abstract][Full Text] [Related]
3. Water-Soluble MMP-9 Inhibitor Reduces Lesion Volume after Severe Traumatic Brain Injury. Lee M; Chen Z; Tomlinson BN; Gooyit M; Hesek D; Juárez MR; Nizam R; Boggess B; Lastochkin E; Schroeder VA; Wolter WR; Suckow MA; Cui J; Mobashery S; Gu Z; Chang M ACS Chem Neurosci; 2015 Oct; 6(10):1658-64. PubMed ID: 26241578 [TBL] [Abstract][Full Text] [Related]
4. MMP-9 inhibitor SB-3CT attenuates behavioral impairments and hippocampal loss after traumatic brain injury in rat. Jia F; Yin YH; Gao GY; Wang Y; Cen L; Jiang JY J Neurotrauma; 2014 Jul; 31(13):1225-34. PubMed ID: 24661104 [TBL] [Abstract][Full Text] [Related]
5. Selective gelatinase inhibitor neuroprotective agents cross the blood-brain barrier. Gooyit M; Suckow MA; Schroeder VA; Wolter WR; Mobashery S; Chang M ACS Chem Neurosci; 2012 Oct; 3(10):730-6. PubMed ID: 23077716 [TBL] [Abstract][Full Text] [Related]
6. Inhibition of MMP-9 by a selective gelatinase inhibitor protects neurovasculature from embolic focal cerebral ischemia. Cui J; Chen S; Zhang C; Meng F; Wu W; Hu R; Hadass O; Lehmidi T; Blair GJ; Lee M; Chang M; Mobashery S; Sun GY; Gu Z Mol Neurodegener; 2012 May; 7():21. PubMed ID: 22587708 [TBL] [Abstract][Full Text] [Related]
7. Synthetic gelatinases inhibitor attenuates electromagnetic pulse-induced blood-brain barrier disruption by inhibiting gelatinases-mediated ZO-1 degradation in rats. Qiu LB; Zhou Y; Wang Q; Yang LL; Liu HQ; Xu SL; Qi YH; Ding GR; Guo GZ Toxicology; 2011 Jul; 285(1-2):31-8. PubMed ID: 21501651 [TBL] [Abstract][Full Text] [Related]
8. Inhibition of MMP-9 activity following hypoxic ischemia in the developing brain using a highly specific inhibitor. Ranasinghe HS; Scheepens A; Sirimanne E; Mitchell MD; Williams CE; Fraser M Dev Neurosci; 2012; 34(5):417-27. PubMed ID: 23171520 [TBL] [Abstract][Full Text] [Related]
9. Neutrophil elastase mediates acute pathogenesis and is a determinant of long-term behavioral recovery after traumatic injury to the immature brain. Semple BD; Trivedi A; Gimlin K; Noble-Haeusslein LJ Neurobiol Dis; 2015 Feb; 74():263-80. PubMed ID: 25497734 [TBL] [Abstract][Full Text] [Related]
10. Matrix metalloproteinase-9 regulates the blood brain barrier via the hedgehog pathway in a rat model of traumatic brain injury. Wu MY; Gao F; Yang XM; Qin X; Chen GZ; Li D; Dang BQ; Chen G Brain Res; 2020 Jan; 1727():146553. PubMed ID: 31734396 [TBL] [Abstract][Full Text] [Related]
11. Small-molecule MMP2/MMP9 inhibitor SB-3CT modulates tumor immune surveillance by regulating PD-L1. Ye Y; Kuang X; Xie Z; Liang L; Zhang Z; Zhang Y; Ma F; Gao Q; Chang R; Lee HH; Zhao S; Su J; Li H; Peng J; Chen H; Yin M; Peng C; Yang N; Wang J; Liu J; Liu H; Han L; Chen X Genome Med; 2020 Sep; 12(1):83. PubMed ID: 32988398 [TBL] [Abstract][Full Text] [Related]
12. Synthesis, kinetic characterization and metabolism of diastereomeric 2-(1-(4-phenoxyphenylsulfonyl)ethyl)thiiranes as potent gelatinase and MT1-MMP inhibitors. Gooyit M; Lee M; Hesek D; Boggess B; Oliver AG; Fridman R; Mobashery S; Chang M Chem Biol Drug Des; 2009 Dec; 74(6):535-46. PubMed ID: 19824893 [TBL] [Abstract][Full Text] [Related]
13. MMP-9 inhibitors impair learning in spontaneously hypertensive rats. Raz L; Yang Y; Thompson J; Hobson S; Pesko J; Mobashery S; Chang M; Rosenberg G PLoS One; 2018; 13(12):e0208357. PubMed ID: 30533010 [TBL] [Abstract][Full Text] [Related]
14. Early Abrogation of Gelatinase Activity Extends the Time Window for tPA Thrombolysis after Embolic Focal Cerebral Ischemia in Mice. Chen S; Chen Z; Cui J; McCrary ML; Song H; Mobashery S; Chang M; Gu Z eNeuro; 2018; 5(3):. PubMed ID: 29963617 [TBL] [Abstract][Full Text] [Related]
15. Synapse loss regulated by matrix metalloproteinases in traumatic brain injury is associated with hypoxia inducible factor-1alpha expression. Ding JY; Kreipke CW; Schafer P; Schafer S; Speirs SL; Rafols JA Brain Res; 2009 May; 1268():125-134. PubMed ID: 19285046 [TBL] [Abstract][Full Text] [Related]
16. Selective Inhibition of MMP-2 Does Not Alter Neurological Recovery after Spinal Cord Injury. Gao M; Zhang H; Trivedi A; Mahasenan KV; Schroeder VA; Wolter WR; Suckow MA; Mobashery S; Noble-Haeusslein LJ; Chang M ACS Chem Neurosci; 2016 Nov; 7(11):1482-1487. PubMed ID: 27551907 [TBL] [Abstract][Full Text] [Related]
17. Moderate and severe traumatic brain injury induce early overexpression of systemic and brain gelatinases. Vilalta A; Sahuquillo J; Rosell A; Poca MA; Riveiro M; Montaner J Intensive Care Med; 2008 Aug; 34(8):1384-92. PubMed ID: 18350273 [TBL] [Abstract][Full Text] [Related]
18. Ethyl pyruvate protects against blood-brain barrier damage and improves long-term neurological outcomes in a rat model of traumatic brain injury. Shi H; Wang HL; Pu HJ; Shi YJ; Zhang J; Zhang WT; Wang GH; Hu XM; Leak RK; Chen J; Gao YQ CNS Neurosci Ther; 2015 Apr; 21(4):374-84. PubMed ID: 25533312 [TBL] [Abstract][Full Text] [Related]
19. Blockade of MMP-2 and MMP-9 inhibits corneal lymphangiogenesis. Du HT; Du LL; Tang XL; Ge HY; Liu P Graefes Arch Clin Exp Ophthalmol; 2017 Aug; 255(8):1573-1579. PubMed ID: 28669039 [TBL] [Abstract][Full Text] [Related]
20. Acute pharmacological inhibition of matrix metalloproteinase-9 activity during development restores perineuronal net formation and normalizes auditory processing in Fmr1 KO mice. Pirbhoy PS; Rais M; Lovelace JW; Woodard W; Razak KA; Binder DK; Ethell IM J Neurochem; 2020 Dec; 155(5):538-558. PubMed ID: 32374912 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]